| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RESEARCH COMMUNICATION |
a Institut für Pharmakologie, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin,D-14195 Berlin, Germany
b Klinik und Poliklinik für Kinderheilkunde, Virchow-Klinikum, Humboldt-Universität zu Berlin
c Institut für Molekulare Pharmakologie, Berlin
In the human thyroid, the wild-type thyrotropin receptor (TSHR) couples to adenylyl cyclase and phospholipase C and constitutively increases intracellular cAMP levels. The first human TSHR sequence submitted differs from subsequently cloned wild-type receptors by an exchange of a conserved Y residue within transmembrane domain 5 (TM5) for an H residue. We did not detect the Y601H mutant in 263 European individuals, but confirmed the homozygous occurrence of TSHR-Y601. Expression of TSHR-Y601H in COS-7 cells revealed a loss of constitutive cAMP production and selective lack of TSH-induced phosphoinositide hydrolysis, whereas agonist-induced cAMP formation remained unaltered. Analysis of several mutant receptors (Y601A, Y601D, Y601F, Y601K, Y601P, Y601S, Y601W, Y601
) did not show restoration of constitutive activity and dual signaling, thus suggesting a functional role of a properly spaced hydroxyl group at position 601. Molecular modeling revealed that the formation of a hydrogen bond between the hydroxyl group of Y601 in TM5 and the carbonyl oxygen of A623 in the peptide backbone of TM6 is critical for the receptor to adopt active conformations that impart wild-type signaling properties. Our findings indicate that multiple active receptor states underlie coupling of a G-protein-coupled receptor to different G-proteins.—Biebermann, H., Schöneberg, T., Schulz, A., Krause, G., Grüters, A., Schultz, G., Gudermann, T. A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J. 12, 1461–1471 (1998)
Key Words: G-protein-coupled receptor • molecular modeling • receptor conformation • thyroid • TSH receptor allele
This article has been cited by other articles:
|
|
 |
|
  T. R. H. Buch, H. Biebermann, H. Kalwa, O. Pinkenburg, D. Hager, H. Barth, K. Aktories, A. Breit, and T. Gudermann G13-dependent Activation of MAPK by Thyrotropin J. Biol. Chem., July 18, 2008; 283(29): 20330 - 20341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-R. Chen, S. M. McLachlan, and B. Rapoport Suppression of Thyrotropin Receptor Constitutive Activity by a Monoclonal Antibody with Inverse Agonist Activity Endocrinology, May 1, 2007; 148(5): 2375 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Nurwakagari, A. Breit, C. Hess, H. Salman-Livny, D. Ben-Menahem, and T. Gudermann A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation J. Mol. Endocrinol., February 1, 2007; 38(2): 259 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kleinau, M. Claus, H. Jaeschke, S. Mueller, S. Neumann, R. Paschke, and G. Krause Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor J. Biol. Chem., January 5, 2007; 282(1): 518 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Karges, G. Krause, J. Homoki, K.-M. Debatin, N. de Roux, and W. Karges TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5 J. Endocrinol., August 1, 2005; 186(2): 377 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter Endocr. Rev., June 1, 2005; 26(4): 504 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Neumann, G. Krause, M. Claus, and R. Paschke Structural Determinants for G Protein Activation and Selectivity in the Second Intracellular Loop of the Thyrotropin Receptor Endocrinology, January 1, 2005; 146(1): 477 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schulz and T. Schoneberg The Structural Evolution of a P2Y-like G-protein-coupled Receptor J. Biol. Chem., September 12, 2003; 278(37): 35531 - 35541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-R. Chen, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Evidence that the C Terminus of the A Subunit Suppresses Thyrotropin Receptor Constitutive Activity Endocrinology, September 1, 2003; 144(9): 3821 - 3827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fuhrer, M. D. Lewis, F. Alkhafaji, K. Starkey, R. Paschke, D. Wynford-Thomas, M. Eggo, and M. Ludgate Biological Activity of Activating Thyroid-Stimulating Hormone Receptor Mutants Depends on the Cellular Context Endocrinology, September 1, 2003; 144(9): 4018 - 4030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-R. Chen, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Targeted Restoration of Cleavage in a Noncleaving Thyrotropin Receptor Demonstrates that Cleavage Is Insufficient to Enhance Ligand-Independent Activity Endocrinology, April 1, 2003; 144(4): 1324 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sangkuhl, A. Schulz, G. Schultz, and T. Schoneberg Structural Requirements for Mutational Lutropin/Choriogonadotropin Receptor Activation J. Biol. Chem., November 27, 2002; 277(49): 47748 - 47755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Prioleau, I. Visiers, B. J. Ebersole, H. Weinstein, and S. C. Sealfon Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor. IDENTIFICATION OF A NOVEL "LOCKED-ON" PHENOTYPE AND DOUBLE REVERTANT MUTATIONS J. Biol. Chem., September 20, 2002; 277(39): 36577 - 36584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Alberti, M. C. Proverbio, S. Costagliola, R. Romoli, B. Boldrighini, M. C. Vigone, G. Weber, G. Chiumello, P. Beck-Peccoz, and L. Persani Germline Mutations of TSH Receptor Gene as Cause of Nonautoimmune Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2549 - 2555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pichurin, O. Pichurina, G. D. Chazenbalk, C. Paras, C.-R. Chen, B. Rapoport, and S. M. McLachlan Immune Deviation Away from Th1 in Interferon-{gamma} Knockout Mice Does Not Enhance TSH Receptor Antibody Production after Naked DNA Vaccination Endocrinology, April 1, 2002; 143(4): 1182 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Szkudlinski, V. Fremont, C. Ronin, and B. D. Weintraub Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Structure-Function Relationships Physiol Rev, April 1, 2002; 82(2): 473 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Q. Nguyen, O. K. Arseven, H. Gerber, B. S. Stein, J. L. Jameson, and P. Kopp Cloning of the Cat TSH Receptor and Evidence Against an Autoimmune Etiology of Feline Hyperthyroidism Endocrinology, February 1, 2002; 143(2): 395 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Neumann, G. Krause, S. Chey, and R. Paschke A Free Carboxylate Oxygen in the Side Chain of Position 674 in Transmembrane Domain 7 Is Necessary for TSH Receptor Activation Mol. Endocrinol., August 1, 2001; 15(8): 1294 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Grundker, P. Volker, and G. Emons Antiproliferative Signaling of Luteinizing Hormone-Releasing Hormone in Human Endometrial and Ovarian Cancer Cells through G Protein {{alpha}}I-Mediated Activation of Phosphotyrosine Phosphatase Endocrinology, June 1, 2001; 142(6): 2369 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Park, H. Kim, J. M. Suh, S. J. Park, S. H. You, H. K. Chung, K. W. Lee, O-Y. Kwon, B. Y. Cho, Y. K. Kim, et al. Involvement of JAK/STAT (Janus Kinase/Signal Transducer and Activator of Transcription) in the Thyrotropin Signaling Pathway Mol. Endocrinol., May 1, 2000; 14(5): 662 - 670. [Abstract] [Full Text]
|
|
|
|
|
|
Z.-L. Lu and E. C. Hulme A Network of Conserved Intramolecular Contacts Defines the Off-state of the Transmembrane Switch Mechanism in a Seven-transmembrane Receptor J. Biol. Chem., February 25, 2000; 275(8): 5682 - 5686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Krause, R. Hermosilla, A. Oksche, C. Rutz, W. Rosenthal, and R. Schülein Molecular and Conformational Features of a Transport-Relevant Domain in the C-Terminal Tail of the Vasopressin V2 Receptor Mol. Pharmacol., February 1, 2000; 57(2): 232 - 242. [Abstract] [Full Text]
|
|
|
|
|
|
A. Schulz, K. Bruns, P. Henklein, G. Krause, M. Schubert, T. Gudermann, V. Wray, G. Schultz, and T. Schoneberg Requirement of Specific Intrahelical Interactions for Stabilizing the Inactive Conformation of Glycoprotein Hormone Receptors J. Biol. Chem., November 22, 2000; 275(48): 37860 - 37869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Govaerts, A. Lefort, S. Costagliola, S. J. Wodak, J. A. Ballesteros, J. Van Sande, L. Pardo, and G. Vassart A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor J. Biol. Chem., June 15, 2001; 276(25): 22991 - 22999. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
